期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Signal Transduction and Targeted Therapy LetPub Score 8.6
51 ratings
Rate
Reputation 9.2 Influence 8.0 Speed 9.3 | ||||||||||||||||||||
期刊簡稱 | SIGNAL TRANSDUCT TAR | ||||||||||||||||||||
ISSN | 2095-9907 | ||||||||||||||||||||
E-ISSN | 2059-3635 | ||||||||||||||||||||
h-index | N.A. | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 1.20%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | http://www.nature.com/sigtrans/ | ||||||||||||||||||||
在線稿件提交 | http://mts-sigtrans.nature.com/ | ||||||||||||||||||||
開放訪問 | Yes | ||||||||||||||||||||
出版商 | Springer Nature | ||||||||||||||||||||
主題領域 | Biochemistry, Genetics and Molecular Biology | ||||||||||||||||||||
出版國/地區 | United Kingdom | ||||||||||||||||||||
發行頻率 | |||||||||||||||||||||
創刊年 | 2016 | ||||||||||||||||||||
每年文章數 | 272每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 99.57% | ||||||||||||||||||||
OA Related Info | APC: Yes( GBP2590; USD3490; EUR2890; ) APC waiver:Check Notes Other charges: No Keywords: molecular biology、cell biology、pharmacology、medicinal chemistry、computational chemistry、systems biology Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2095-9907%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: 5 Weeks | ||||||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Signal Transduction and Targeted Therapy] 的評論 | 撰寫評論 |
作者: 科研兴趣小组 領域: 生物学 審稿時間: 2.0 month(s) 結果: 直接被接受 撰寫評論 |
2023-08-09 15:56:45 評論於 I don't understand why there are so many sour grape mentality people who can't stand to see domestic journals improve. Is mindlessly criticizing interesting? If you have the ability, publish an article there and then speak. Anyway, if our papers are not accepted by top-tier journals or major journals, we will consider submitting them here, but it is also difficult to get accepted. Many papers that were rejected by STTT were accepted by NC, and there are quite a few accepted by Cell Reports. At the very least, this proves that STTT has a higher difficulty level for manuscript submission compared to regular journals.(0) 讚! | 科研兴趣小组 |
作者: 科研搬砖民工 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-04-26 10:50:19 評論於 The quality is not that bad, but when will domestic journals stop the farce of impact factor?(24) 讚! | 科研搬砖民工 |
作者: prion1 領域: 生物学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2022-07-19 19:29:48 評論於 Submitted in March this year, reviewed for a month, major revisions! Was given a month to make the necessary modifications, then requested an additional month of revision with the editor; revised and resubmitted in June, minor revisions were made during the second review and it was provisionally accepted; in early July, the editorial department made the requested modifications to the images and officially accepted it! The entire process took less than 5 months, showcasing the editors' high efficiency. Wishing everyone success, and may the magazine thrive even further!(44) 讚! | prion1 |
作者: cpupierce 領域: 医学 審稿時間: 2.0 month(s) 結果: 直接被接受 撰寫評論 |
2022-07-04 00:33:45 評論於 Received, the reviewer's comments are very professional, but the handling of the manuscript is slow.(0) 讚! | cpupierce |
作者: 张晓梅 領域: 生物学 審稿時間: 1.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-03-26 09:32:10 評論於 Although the impact factor is increasing rapidly, most of the impact factors are achieved through letter publications, and it is easier to be accepted by submitting in letter format. However, it is important to remind everyone that a small number of institutions have regulations that letters (excluding Nature's letters) are not considered articles and cannot be used for promotion or awards. Considering this trend, the publication volume of letters in domestic journals is very high, leading to internal competition, and only raising assessment standards. I believe that this trend will continue to spread in the future. Those who want to go far in scientific research should carefully consider submitting letters, including letters from Cell Research, as they may no longer be considered articles in the future.(75) 讚! | 张晓梅 |
作者: 布鲁斯 領域: 医学 審稿時間: 1.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-03-17 19:56:46 評論於 Now there are many manuscripts, not the level of a 5-minute article two years ago. No matter how much is said, go and see the quality of the article for yourself. It's a very good magazine.(18) 讚! | 布鲁斯 |
作者: 全式金 領域: 生物 審稿時間: 1.0 month(s) 結果: 直接被接受 撰寫評論 |
2020-10-29 09:09:30 評論於 How do I say? One article submitted by junior sister apprentice was rejected successively by Oncogene, EBioMedicine, and Cell Death. Later, the supervisor said that this journal had a high impact factor and suggested to submit to it. The impact factor was over 5 in 2018, and it is 14 in 2020. The impact factor has been hyped, and the actual level is estimated to be around 5. (48) 讚! | 全式金 |
作者: 全式金 領域: 生物 審稿時間: 1.0 month(s) 結果: 直接被接受 撰寫評論 |
2020-10-29 09:08:05 評論於 How do I say? One article submitted by junior sister apprentice was rejected successively by Oncogene, EBioMedicine, and Cell Death. (0) 讚! | 全式金 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us